Bunkyo, Japan Fast Track Initiative is the famous VC, which was founded in 2004. The leading representative office of defined VC is situated in the Tokyo. The company was established in Asia in Japan.
This organization was formed by Hiromichi Kimura.
Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2018.
The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - Japan. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Education, Life Science. Among the most popular portfolio startups of the fund, we may highlight AccuRna, Braizon Therapeutics, Inc., Modulus Discovery.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fast Track Initiative, startups are often financed by SMBC Venture Capital, SBI Investment, UTokyo Innovation Platform. The meaningful sponsors for the fund in investment in the same round are SMBC Venture Capital, UTokyo Innovation Platform, SBI Investment. In the next rounds fund is usually obtained by SMBC Venture Capital, SBI Investment, Mitsubishi UFJ Capital.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Metagen Therapeutics | $5M | 15 Jun 2023 | Tsuruoka, Yamagata Prefecture, Japan | ||
Metagen Therapeutics | $10M | 03 Apr 2023 | Tsuruoka, Yamagata Prefecture, Japan | ||
Storm Therapeutics | $30M | 14 Dec 2022 | Cambridge, England, United Kingdom | ||
Metagen Therapeutics | $1M | 06 Oct 2022 | Tsuruoka, Yamagata Prefecture, Japan | ||
Varinos | 03 Aug 2022 | Minato, Japan | |||
reverSASP | 07 Jul 2022 | Tokyo, Kantō, Japan | |||
mediPhone | $10M | 30 Jun 2022 | Chiyoda, Japan | ||
LUCA Science | $35M | 06 Jun 2022 | Chiyoda, Japan | ||
Celsius Therapeutics | $83M | 24 Mar 2022 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Metagen Therapeutics | $5M | 15 Jun 2023 | Tsuruoka, Yamagata Prefecture, Japan | ||
Metagen Therapeutics | $10M | 03 Apr 2023 | Tsuruoka, Yamagata Prefecture, Japan | ||
Storm Therapeutics | $30M | 14 Dec 2022 | Cambridge, England, United Kingdom | ||
Metagen Therapeutics | $1M | 06 Oct 2022 | Tsuruoka, Yamagata Prefecture, Japan | ||
Varinos | 03 Aug 2022 | Minato, Japan | |||
reverSASP | 07 Jul 2022 | Tokyo, Kantō, Japan | |||
mediPhone | $10M | 30 Jun 2022 | Chiyoda, Japan | ||
LUCA Science | $35M | 06 Jun 2022 | Chiyoda, Japan | ||
Celsius Therapeutics | $83M | 24 Mar 2022 | Cambridge, Massachusetts, United States |
